Most Clicked StoriesMore >


Bayer suspends radium-223 production

SNMMI SmartBrief | Oct 17, 2014

Bayer HealthCare Pharmaceuticals has halted production of prostate cancer drug radium-223, sold as Xofigo, because of problems with manufacturing. Supplies of the drug have been limited since Oct. 7, according to the FDA. Bayer said it is communicating with the FDA and providers about the issue, but it had no estimate regarding when production will resume. OncLive (10/15)


Tc-99m prices expected to rise, Mallinckrodt warns

SNMMI SmartBrief | Oct 21, 2014

OctreoPharm's radiotracer gains orphan drug status in U.S.

SNMMI SmartBrief | Oct 21, 2014

Ketamine rapidly reverses symptom of bipolar disorder

SNMMI SmartBrief | Oct 21, 2014

N.H. breast-imaging device startup obtains $6.5M

SNMMI SmartBrief | Oct 17, 2014

"Updates on Ga-68: Outlook for the Future" webinar Thursday at 3 p.m. ET

SNMMI SmartBrief | Oct 20, 2014

CDC issues new Ebola guidelines for health care workers

SNMMI SmartBrief | Oct 21, 2014

Head injury allows immune system to attack brain cells, study finds

SNMMI SmartBrief | Oct 22, 2014

Agents show promise in colorectal cancer detection

SNMMI SmartBrief | Oct 17, 2014

Ebola: What you should know about management and response

SNMMI SmartBrief | Oct 20, 2014


Find SNMMI SmartBrief Issues by Date:



SNMMI News More >


SNMMI Councils/Centers Internship Program: Call for applications

SNMMI SmartBrief | Oct 24, 2014

State-of-the-Art Molecular Imaging in Cancer Biology & Therapy conference abstract deadline: Oct. 31

SNMMI SmartBrief | Oct 24, 2014

Renew your SNMMI membership

SNMMI SmartBrief | Oct 23, 2014

Registration is now open for the SNMMI 2015 Annual Meeting

SNMMI SmartBrief | Oct 23, 2014

SNMMI 2015 Future Leaders Academy: Application deadline Oct. 31

SNMMI SmartBrief | Oct 22, 2014




Sign up for SNMMI SmartBrief



Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession. Learn more